ChartMill assigns a Buy % Consensus number of 52% to CCXI. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-08-10 | Stifel | Downgrade | Buy -> Hold |
| 2022-08-05 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-08-05 | Raymond James | Downgrade | Strong Buy -> Market Perform |
| 2022-08-05 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2022-08-05 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-05-06 | Raymond James | Maintains | Strong Buy |
| 2021-11-10 | Raymond James | Maintains | Strong Buy |
| 2021-10-11 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2021-10-11 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2021-10-11 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2021-10-08 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2021-07-07 | Stifel | Upgrade | Hold -> Buy |
| 2021-05-07 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2021-05-07 | Stifel | Downgrade | Buy -> Hold |
| 2021-05-07 | Raymond James | Downgrade | Strong Buy -> Outperform |
| 2021-05-07 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2021-05-07 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2021-05-07 | HC Wainwright & Co. | Maintains | Buy |
| 2021-03-02 | Stifel | Initiate | Buy |
| 2021-03-02 | Raymond James | Maintains | Strong Buy |
13 analysts have analysed CCXI and the average price target is 53.04 USD. This implies a price increase of 2.02% is expected in the next year compared to the current price of 51.99.
The consensus rating for CHEMOCENTRYX INC (CCXI) is 52.3077 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
The number of analysts covering CHEMOCENTRYX INC (CCXI) is 13.